StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | INSM Insmed | $106.91 | -1.35% | $23.2B | — | 28.3 | +115.1% | 81.8% | 53 |
| 1 | MRNA Moderna | $47.19 | -0.80% | $18.7B | — | 8.4 | -30.0% | 35.0% | 54 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $223.37 |
| +4.41% |
| $32.0B |
| — |
| 12.8 |
| +36.6% |
| 65.1% |
| 50 |
| 3 | ALNY Alnylam Pharmaceuticals | $301.98 | -1.01% | $40.3B | 69.8 | 9.4 | +82.6% | 80.8% | 49 |
| 4 | INCY Incyte | $96.74 | -0.78% | $19.3B | 13.5 | 3.6 | +21.5% | 93.0% | 48 |
| 5 | BIIB Biogen | $196.00 | -0.20% | $28.9B | 21.1 | 2.9 | +1.2% | 75.5% | 45 |
| 6 | NBIX Neurocrine Biosciences | $158.30 | +1.22% | $15.9B | 23.8 | 5.1 | +28.6% | 98.2% | 45 |
| 7 | UTHR United Therapeutics | $556.82 | -0.94% | $23.8B | 18.5 | 7.5 | +5.9% | 86.6% | 40 |
| 8 | RVMD RVMD | $157.48 | +1.84% | $33.5B | — | 2893.2 | — | — | — |
| 9 | SMMT SMMT | $17.54 | +0.75% | $13.6B | — | 14181.1 | — | — | — |